Skip to main content
TipRanks
Go Ultimate75% OFF

CanSino Biologics, Inc. Class H (6185) Income Statement

7 Followers

CanSino Biologics, Inc. Class H Income Statement

Last quarter (Q3 2026), CanSino Biologics, Inc. Class H's total revenue was ¥332.43M, an increase of 7.19% from the same quarter last year. In Q3, CanSino Biologics, Inc. Class H's net income was ¥17.01M. See CanSino Biologics, Inc. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
¥ 1.03B¥ 846.34M¥ 345.18M¥ 1.03B¥ 4.30B
¥ 681.82M¥ 601.91M¥ -876.02M¥ -186.61M¥ 3.00B
¥ 794.94M¥ 958.80M¥ 1.16B¥ 1.18B¥ 1.20B
Depreciation and Amortization¥ 174.10M¥ 211.38M¥ 269.05M¥ 196.36M¥ 88.54M
¥ 60.98M¥ -163.84M¥ -1.65B¥ -1.30B¥ 1.87B
¥ -113.12M¥ -375.22M¥ -2.04B¥ -1.37B¥ 1.94B
¥ 134.30M¥ -5.98M¥ 56.30M¥ 184.74M¥ -4.01M
¥ 21.18M¥ -381.20M¥ -1.98B¥ -1.18B¥ 1.94B
¥ 27.15M¥ -378.88M¥ -1.48B¥ -909.43M¥ 1.91B
Per Share Metrics
Basic EPS¥ 0.11¥ -1.53¥ -6.01¥ -3.68¥ 7.74
Diluted EPS¥ 0.11¥ -1.53¥ -6.01¥ -3.68¥ 7.74
Weighted Average Shares Outstanding253.38M247.64M246.77M247.02M247.45M
Weighted Average Shares Outstanding (Diluted)253.38M247.64M246.77M247.02M247.45M

Currency in CNY

CanSino Biologics, Inc. Class H Earnings and Revenue History

-2.5B02.5B5B-16000 %-8000 %0 %8000 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin